Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1998 Feb;77(4):522–529. doi: 10.1038/bjc.1998.85

Comparative analysis of integrins in vitro and in vivo in uveal and cutaneous melanomas.

J F Marshall 1, D C Rutherford 1, L Happerfield 1, A Hanby 1, A C McCartney 1, J Newton-Bishop 1, I R Hart 1
PMCID: PMC2149935  PMID: 9484806

Abstract

Changes in integrin expression have been shown to be important for the growth and metastatic capacity of melanoma cells. In this study, we have examined the expression of alphav integrins by three uveal and four cutaneous malanoma lines. No lines expressed alphavbeta6 and only TXM13, a cutaneous line, expressed alphavbeta8. All lines expressed alphavbeta5 and alphavbeta3 (four out of four cutaneous, two out of three uveal) or avpl (OM431, an uveal line). Thus, OM431 is the second uveal melanoma we have described that expresses alphavbeta1 and this, we report again, functions as an alternative vitronectin/fibronectin receptor. Subcutaneous growth of cell lines in athymic mice correlated with an alphavbeta3-positive, alphavbeta1 -negative phenotype. Analysis of clinical material from cutaneous melanoma showed that although alphav expression was increased in 88% of metastases, this could not all be explained by up-regulation of alphavbeta3, with only 2 out of eight skin metastases expressing this heterodimer. Using antibody SZ.21, which as we report here works in archival material, only 1 out of 15 uveal metastases expressed detectable beta3. Thus, acquisition of alphavbeta3 expression, which has been implicated in cutaneous melanoma progression, may not be required for development of metastases from uveal melanoma or indeed for skin, as distinct from lymph node, metastases of cutaneous melanoma.

Full text

PDF
522

Images in this article

525Figure 1
on p.525

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Albelda S. M., Mette S. A., Elder D. E., Stewart R., Damjanovich L., Herlyn M., Buck C. A. Integrin distribution in malignant melanoma: association of the beta 3 subunit with tumor progression. Cancer Res. 1990 Oct 15;50(20):6757–6764. [PubMed] [Google Scholar]
  2. Boukerche H., Benchaibi M., Berthier-Vergnes O., Lizard G., Bailly M., Bailly M., McGregor J. L. Two human melanoma cell-line variants with enhanced in vivo tumor growth and metastatic capacity do not express the beta 3 integrin subunit. Eur J Biochem. 1994 Mar 1;220(2):485–491. doi: 10.1111/j.1432-1033.1994.tb18647.x. [DOI] [PubMed] [Google Scholar]
  3. Boukerche H., Berthier-Vergnes O., Bailly M., Doré J. F., Leung L. L., McGregor J. L. A monoclonal antibody (LYP18) directed against the blood platelet glycoprotein IIb/IIIa complex inhibits human melanoma growth in vivo. Blood. 1989 Aug 15;74(3):909–912. [PubMed] [Google Scholar]
  4. Brooks P. C., Strömblad S., Sanders L. C., von Schalscha T. L., Aimes R. T., Stetler-Stevenson W. G., Quigley J. P., Cheresh D. A. Localization of matrix metalloproteinase MMP-2 to the surface of invasive cells by interaction with integrin alpha v beta 3. Cell. 1996 May 31;85(5):683–693. doi: 10.1016/s0092-8674(00)81235-0. [DOI] [PubMed] [Google Scholar]
  5. Carter W. G., Wayner E. A., Bouchard T. S., Kaur P. The role of integrins alpha 2 beta 1 and alpha 3 beta 1 in cell-cell and cell-substrate adhesion of human epidermal cells. J Cell Biol. 1990 Apr;110(4):1387–1404. doi: 10.1083/jcb.110.4.1387. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Cheresh D. A., Spiro R. C. Biosynthetic and functional properties of an Arg-Gly-Asp-directed receptor involved in human melanoma cell attachment to vitronectin, fibrinogen, and von Willebrand factor. J Biol Chem. 1987 Dec 25;262(36):17703–17711. [PubMed] [Google Scholar]
  7. Danen E. H., Jansen K. F., Van Kraats A. A., Cornelissen I. M., Ruiter D. J., Van Muijen G. N. Alpha v-integrins in human melanoma: gain of alpha v beta 3 and loss of alpha v beta 5 are related to tumor progression in situ but not to metastatic capacity of cell lines in nude mice. Int J Cancer. 1995 May 16;61(4):491–496. doi: 10.1002/ijc.2910610411. [DOI] [PubMed] [Google Scholar]
  8. Danen E. H., Ten Berge P. J., Van Muijen G. N., Van 't Hof-Grootenboer A. E., Bröcker E. B., Ruiter D. J. Emergence of alpha 5 beta 1 fibronectin- and alpha v beta 3 vitronectin-receptor expression in melanocytic tumour progression. Histopathology. 1994 Mar;24(3):249–256. doi: 10.1111/j.1365-2559.1994.tb00517.x. [DOI] [PubMed] [Google Scholar]
  9. Davies J., Warwick J., Totty N., Philp R., Helfrich M., Horton M. The osteoclast functional antigen, implicated in the regulation of bone resorption, is biochemically related to the vitronectin receptor. J Cell Biol. 1989 Oct;109(4 Pt 1):1817–1826. doi: 10.1083/jcb.109.4.1817. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Felding-Habermann B., Mueller B. M., Romerdahl C. A., Cheresh D. A. Involvement of integrin alpha V gene expression in human melanoma tumorigenicity. J Clin Invest. 1992 Jun;89(6):2018–2022. doi: 10.1172/JCI115811. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Fradet Y., Cordon-Cardo C., Thomson T., Daly M. E., Whitmore W. F., Jr, Lloyd K. O., Melamed M. R., Old L. J. Cell surface antigens of human bladder cancer defined by mouse monoclonal antibodies. Proc Natl Acad Sci U S A. 1984 Jan;81(1):224–228. doi: 10.1073/pnas.81.1.224. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Gui G. P., Puddefoot J. R., Vinson G. P., Wells C. A., Carpenter R. Altered cell-matrix contact: a prerequisite for breast cancer metastasis? Br J Cancer. 1997;75(5):623–633. doi: 10.1038/bjc.1997.113. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Hynes R. O. Integrins: versatility, modulation, and signaling in cell adhesion. Cell. 1992 Apr 3;69(1):11–25. doi: 10.1016/0092-8674(92)90115-s. [DOI] [PubMed] [Google Scholar]
  14. Kramer R. H., Vu M., Cheng Y. F., Ramos D. M. Integrin expression in malignant melanoma. Cancer Metastasis Rev. 1991 May;10(1):49–59. doi: 10.1007/BF00046843. [DOI] [PubMed] [Google Scholar]
  15. Marshall J. F., Hart I. R. The role of alpha v-integrins in tumour progression and metastasis. Semin Cancer Biol. 1996 Jun;7(3):129–138. doi: 10.1006/scbi.1996.0018. [DOI] [PubMed] [Google Scholar]
  16. Marshall J. F., Nesbitt S. A., Helfrich M. H., Horton M. A., Polakova K., Hart I. R. Integrin expression in human melanoma cell lines: heterogeneity of vitronectin receptor composition and function. Int J Cancer. 1991 Dec 2;49(6):924–931. doi: 10.1002/ijc.2910490621. [DOI] [PubMed] [Google Scholar]
  17. Marshall J. F., Rutherford D. C., McCartney A. C., Mitjans F., Goodman S. L., Hart I. R. Alpha v beta 1 is a receptor for vitronectin and fibrinogen, and acts with alpha 5 beta 1 to mediate spreading on fibronectin. J Cell Sci. 1995 Mar;108(Pt 3):1227–1238. doi: 10.1242/jcs.108.3.1227. [DOI] [PubMed] [Google Scholar]
  18. Meredith J. E., Jr, Schwartz M. A. Integrins, adhesion and apoptosis. Trends Cell Biol. 1997 Apr;7(4):146–150. doi: 10.1016/S0962-8924(97)01002-7. [DOI] [PubMed] [Google Scholar]
  19. Mitjans F., Sander D., Adán J., Sutter A., Martinez J. M., Jäggle C. S., Moyano J. M., Kreysch H. G., Piulats J., Goodman S. L. An anti-alpha v-integrin antibody that blocks integrin function inhibits the development of a human melanoma in nude mice. J Cell Sci. 1995 Aug;108(Pt 8):2825–2838. doi: 10.1242/jcs.108.8.2825. [DOI] [PubMed] [Google Scholar]
  20. Montgomery A. M., Reisfeld R. A., Cheresh D. A. Integrin alpha v beta 3 rescues melanoma cells from apoptosis in three-dimensional dermal collagen. Proc Natl Acad Sci U S A. 1994 Sep 13;91(19):8856–8860. doi: 10.1073/pnas.91.19.8856. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Mould A. P., Askari J. A., Craig S. E., Garratt A. N., Clements J., Humphries M. J. Integrin alpha 4 beta 1-mediated melanoma cell adhesion and migration on vascular cell adhesion molecule-1 (VCAM-1) and the alternatively spliced IIICS region of fibronectin. J Biol Chem. 1994 Nov 4;269(44):27224–27230. [PubMed] [Google Scholar]
  22. Natali P. G., Hamby C. V., Felding-Habermann B., Liang B., Nicotra M. R., Di Filippo F., Giannarelli D., Temponi M., Ferrone S. Clinical significance of alpha(v)beta3 integrin and intercellular adhesion molecule-1 expression in cutaneous malignant melanoma lesions. Cancer Res. 1997 Apr 15;57(8):1554–1560. [PubMed] [Google Scholar]
  23. Natali P. G., Nicotra M. R., Bartolazzi A., Cavaliere R., Bigotti A. Integrin expression in cutaneous malignant melanoma: association of the alpha 3/beta 1 heterodimer with tumor progression. Int J Cancer. 1993 Apr 22;54(1):68–72. doi: 10.1002/ijc.2910540112. [DOI] [PubMed] [Google Scholar]
  24. Natali P. G., Nicotra M. R., Cavaliere R., Giannarelli D., Bigotti A. Tumor progression in human malignant melanoma is associated with changes in alpha 6/beta 1 laminin receptor. Int J Cancer. 1991 Sep 9;49(2):168–172. doi: 10.1002/ijc.2910490203. [DOI] [PubMed] [Google Scholar]
  25. Nip J., Shibata H., Loskutoff D. J., Cheresh D. A., Brodt P. Human melanoma cells derived from lymphatic metastases use integrin alpha v beta 3 to adhere to lymph node vitronectin. J Clin Invest. 1992 Oct;90(4):1406–1413. doi: 10.1172/JCI116007. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Nishimura S. L., Sheppard D., Pytela R. Integrin alpha v beta 8. Interaction with vitronectin and functional divergence of the beta 8 cytoplasmic domain. J Biol Chem. 1994 Nov 18;269(46):28708–28715. [PubMed] [Google Scholar]
  27. Palecek S. P., Loftus J. C., Ginsberg M. H., Lauffenburger D. A., Horwitz A. F. Integrin-ligand binding properties govern cell migration speed through cell-substratum adhesiveness. Nature. 1997 Feb 6;385(6616):537–540. doi: 10.1038/385537a0. [DOI] [PubMed] [Google Scholar]
  28. Pellegrini R., Bazzini P., Tosi E., Tagliabue E., Conforti G., Dejana E., Ménard S., Colnaghi M. I. Production and characterization of two monoclonal antibodies directed against the integrin beta 1 chain. Tumori. 1992 Feb 29;78(1):1–4. doi: 10.1177/030089169207800101. [DOI] [PubMed] [Google Scholar]
  29. Schadendorf D., Gawlik C., Haney U., Ostmeier H., Suter L., Czarnetzki B. M. Tumour progression and metastatic behaviour in vivo correlates with integrin expression on melanocytic tumours. J Pathol. 1993 Aug;170(4):429–434. doi: 10.1002/path.1711700405. [DOI] [PubMed] [Google Scholar]
  30. Seftor R. E., Seftor E. A., Gehlsen K. R., Stetler-Stevenson W. G., Brown P. D., Ruoslahti E., Hendrix M. J. Role of the alpha v beta 3 integrin in human melanoma cell invasion. Proc Natl Acad Sci U S A. 1992 Mar 1;89(5):1557–1561. doi: 10.1073/pnas.89.5.1557. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Sonnenberg A., Janssen H., Hogervorst F., Calafat J., Hilgers J. A complex of platelet glycoproteins Ic and IIa identified by a rat monoclonal antibody. J Biol Chem. 1987 Jul 25;262(21):10376–10383. [PubMed] [Google Scholar]
  32. Wayner E. A., Carter W. G., Piotrowicz R. S., Kunicki T. J. The function of multiple extracellular matrix receptors in mediating cell adhesion to extracellular matrix: preparation of monoclonal antibodies to the fibronectin receptor that specifically inhibit cell adhesion to fibronectin and react with platelet glycoproteins Ic-IIa. J Cell Biol. 1988 Nov;107(5):1881–1891. doi: 10.1083/jcb.107.5.1881. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Wayner E. A., Garcia-Pardo A., Humphries M. J., McDonald J. A., Carter W. G. Identification and characterization of the T lymphocyte adhesion receptor for an alternative cell attachment domain (CS-1) in plasma fibronectin. J Cell Biol. 1989 Sep;109(3):1321–1330. doi: 10.1083/jcb.109.3.1321. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Wayner E. A., Orlando R. A., Cheresh D. A. Integrins alpha v beta 3 and alpha v beta 5 contribute to cell attachment to vitronectin but differentially distribute on the cell surface. J Cell Biol. 1991 May;113(4):919–929. doi: 10.1083/jcb.113.4.919. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Weinacker A., Chen A., Agrez M., Cone R. I., Nishimura S., Wayner E., Pytela R., Sheppard D. Role of the integrin alpha v beta 6 in cell attachment to fibronectin. Heterologous expression of intact and secreted forms of the receptor. J Biol Chem. 1994 Mar 4;269(9):6940–6948. [PubMed] [Google Scholar]
  36. ten Berge P. J., Danen E. H., van Muijen G. N., Jager M. J., Ruiter D. J. Integrin expression in uveal melanoma differs from cutaneous melanoma. Invest Ophthalmol Vis Sci. 1993 Dec;34(13):3635–3640. [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES